|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| C07D 471/04 | |||
| C07D 513/04 | |||
| A61K 31/5025 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2892904 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13832587.3 |
| Europos patento paraiškos padavimo data | 2013-08-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2013/080598 |
| Data | 2013-08-01 |
| (87) | Numeris | WO 2014/032498 |
| Data | 2014-03-06 |
| (30) | Numeris | Data | Šalis |
| 201210322359 | 2012-09-03 | CN |
| (72) |
ZHONG, Boyu, CN
SHIH, Chuan, CN
YUAN, Hongbin, CN
ZHOU, Feng, CN
|
| (73) |
CB Therapeutics Inc.,
c/o Codan Trust Company (Cayman) Limited Boundary Hall, 2nd Floor Cricket Square, PO Box 2681, Grand Cayman KY1-1111,
KY
|
| (54) | HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS |
| HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS |